Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility

  • González-Serna, David
  • Carmona, Elio G.
  • Ortego-Centeno, Norberto|||0000-0003-2325-0937
  • Simeón-Aznar, Carmen Pilar|||0000-0003-3390-9029
  • Solans, Roser|||0000-0002-0058-1293
  • Hernández Rodríguez, José|||0000-0002-2357-2015
  • Tolosa, Carlos
  • Castañeda, Santos|||0000-0002-7748-853X
  • Narváez, Javier|||0000-0002-1614-8064
  • Martinez-Valle, Ferran
  • Witte, Torsten
  • Neumann, Thomas
  • Holle, Julia
  • Beretta, Lorenzo|||0000-0002-6529-6258
  • Boiardi, Luigi
  • Emmi, Giacomo|||0000-0001-9575-8321
  • Cimmino, Marco Amedeo|||0000-0002-6956-7860
  • Vaglio, Augusto
  • Herrick, Ariane|||0000-0003-4941-7926
  • Denton, Christopher P.
  • Salvarani, Carlo|||0000-0001-5426-5133
  • Cid, María Cinta|||0000-0002-4730-0938
  • Morgan, Ann W.
  • Fonseca, Carmen
  • Gonzalez-Gay, MA.|||0000-0002-7924-7406
  • Martín, Javier|||0000-0002-2202-0622
  • Márquez, Ana|||0000-0001-9913-7688
The TNFSF13B (TNF superfamily member 13b) gene encodes BAFF, a cytokine with a crucial role in the differentiation and activation of B cells. An insertion-deletion variant (GCTGT→A) of this gene, leading to increased levels of BAFF, has been recently implicated in the genetic predisposition to several autoimmune diseases, including multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. Based on the elevated levels of this cytokine found in patients with giant cell arteritis (GCA) and systemic sclerosis (SSc), we aimed to assess whether this functional variant also represents a novel genetic risk factor for these two disorders. A total of 1,728 biopsy-proven GCA patients from 4 European cohorts, 4,584 SSc patients from 3 European cohorts and 5,160 ethnically-matched healthy controls were included in the study. The single nucleotide polymorphism (SNP) rs374039502, which colocalizes with the genetic variant previously implicated in autoimmunity, was genotyped using a custom TaqMan assay. First, association analysis was conducted in each independent cohort using χ2 test in Plink (v1.9). Subsequently, different case/control sets were meta-analyzed by the inverse variance method. No statistically significant differences were found when allele distributions were compared between cases and controls for any of the analyzed cohorts. Similarly, combined analysis of the different sets evidenced a lack of association of the rs374039502 variant with GCA (P = 0.421; OR (95% CI) = 0.92 (0.75-1.13)) and SSc (P = 0.500; OR (95% CI) = 1.05 (0.91-1.22)). The stratified analysis considering the main clinical subphenotypes of these diseases yielded similar negative results. Our data suggest that the TNFSF13B functional variant does not contribute to the genetic network underlying GCA and SSc.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Methylome and transcriptome profiling of giant cell arteritis monocytes reveals novel pathways involved in disease pathogenesis and molecular response to glucocorticoids

  • Estupiñán-Moreno, Elkyn|||0000-0002-5818-4389
  • Ortiz-Fernández, Lourdes|||0000-0002-0247-4280
  • Li, Tianlu|||0000-0001-7152-4870
  • Hernández Rodríguez, José|||0000-0002-2357-2015
  • Ciudad, Laura|||0000-0002-5219-6792
  • Andrés-León, Eduardo|||0000-0002-0621-9914
  • Terron-Camero, Laura Carmen
  • Prieto-González, Sergio|||0000-0003-3179-597X
  • Espígol Frigolé, Georgina|||0000-0002-8299-0209
  • Cid, María Cinta|||0000-0002-4730-0938
  • Márquez, Ana|||0000-0001-9913-7688
  • Ballestar, Esteban|||0000-0002-1400-2440
  • Martín, Javier|||0000-0002-2202-0622
Objectives Giant cell arteritis (GCA) is a complex systemic vasculitis mediated by the interplay between both genetic and epigenetic factors. Monocytes are crucial players of the inflammation occurring in GCA. Therefore, characterisation of the monocyte methylome and transcriptome in GCA would be helpful to better understand disease pathogenesis. Methods We performed an integrated epigenome-and transcriptome-wide association study in CD14+ monocytes from 82 patients with GCA, cross-sectionally classified into three different clinical statuses (active, in remission with or without glucocorticoid (GC) treatment), and 31 healthy controls. Results We identified a global methylation and gene expression dysregulation in GCA monocytes. Specifically, monocytes from active patients showed a more proinflammatory phenotype compared with healthy controls and patients in remission. In addition to inflammatory pathways known to be involved in active GCA, such as response to IL-6 and IL-1, we identified response to IL-11 as a new pathway potentially implicated in GCA. Furthermore, monocytes from patients in remission with treatment showed downregulation of genes involved in inflammatory processes as well as overexpression of GC receptor-target genes. Finally, we identified changes in DNA methylation correlating with alterations in expression levels of genes with a potential role in GCA pathogenesis, such as ITGA7 and CD63, as well as genes mediating the molecular response to GC, including FKBP5, ETS2, ZBTB16 and ADAMTS2. Conclusion Our results revealed profound alterations in the methylation and transcriptomic profiles of monocytes from GCA patients, uncovering novel genes and pathways involved in GCA pathogenesis and in the molecular response to GC treatment.